AI Engines For more Details: Perplexity Kagi Labs You
Anaphylaxis Risk: Lupin allergy is relatively common, particularly in individuals with peanut or soy allergies. Consumption of lupin or lupin-derived products can trigger severe allergic reactions, including anaphylaxis, in sensitive individuals. Those with lupin allergies should avoid lupin-containing foods and products, including lupin kernel fiber.
Toxicity Concerns: Raw or improperly processed lupin seeds contain alkaloids and other compounds that can be toxic to humans if consumed in large quantities. To mitigate this risk, lupin seeds must undergo appropriate processing methods, such as soaking, boiling, or fermentation, to reduce the levels of toxic compounds and make them safe for consumption. It's essential to follow recommended preparation methods and guidelines when incorporating lupin kernel fiber into the diet to ensure safety.
| Rank | Probiotic | Impact |
|---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Acne | 0.4 | 1.2 | -2 |
| ADHD | 0.2 | 1.8 | -8 |
| Age-Related Macular Degeneration and Glaucoma | 0.7 | 0.4 | 0.75 |
| Allergic Rhinitis (Hay Fever) | 0.2 | -0.2 | |
| Allergies | 1.4 | 0.8 | 0.75 |
| Allergy to milk products | 0.6 | 0.6 | |
| Alopecia (Hair Loss) | 1 | 1 | |
| Alzheimer's disease | 0.8 | 2.7 | -2.38 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.9 | 1.6 | -0.78 |
| Ankylosing spondylitis | 0.8 | 0.8 | 0 |
| Anorexia Nervosa | 0.2 | 0.9 | -3.5 |
| Asthma | 1.1 | 0.3 | 2.67 |
| Atherosclerosis | 0.7 | -0.7 | |
| Atrial fibrillation | 0.7 | 0.7 | |
| Autism | 1.5 | 2.9 | -0.93 |
| Bipolar Disorder | 0.3 | 0.3 | 0 |
| Brain Trauma | 0.2 | 0.5 | -1.5 |
| Carcinoma | 1 | 1 | 0 |
| Celiac Disease | 0.3 | 0.9 | -2 |
| Chronic Fatigue Syndrome | 2.1 | -2.1 | |
| Chronic Kidney Disease | 0.5 | -0.5 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.3 | 0.5 | -0.67 |
| Coagulation / Micro clot triggering bacteria | 0.5 | 0.5 | 0 |
| Colorectal Cancer | 1.3 | 0.8 | 0.63 |
| Constipation | 0.4 | 0.4 | |
| Coronary artery disease | 0.3 | 0.8 | -1.67 |
| COVID-19 | 0.7 | 2.4 | -2.43 |
| Crohn's Disease | 1.6 | 2.4 | -0.5 |
| deep vein thrombosis | 0.5 | -0.5 | |
| Depression | 2.8 | 2.7 | 0.04 |
| Dermatomyositis | 0.3 | -0.3 | |
| Eczema | 0.5 | -0.5 | |
| Endometriosis | 0.8 | 0.2 | 3 |
| Eosinophilic Esophagitis | 0.9 | -0.9 | |
| Epilepsy | 0.7 | 0.5 | 0.4 |
| erectile dysfunction | 0.3 | 0.3 | |
| Fibromyalgia | 0.7 | 0.8 | -0.14 |
| Functional constipation / chronic idiopathic constipation | 0.7 | 0.3 | 1.33 |
| gallstone disease (gsd) | 0.5 | 0.5 | 0 |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.3 | 0.3 | |
| Glioblastoma | 1.1 | 0.3 | 2.67 |
| Gout | 0.3 | -0.3 | |
| Graves' disease | 1.7 | -1.7 | |
| Halitosis | 0.7 | 0.7 | |
| Hashimoto's thyroiditis | 0.8 | 0.6 | 0.33 |
| Hemorrhoidal disease, Hemorrhoids, Piles | 1.2 | 1.2 | |
| Hidradenitis Suppurativa | 0.3 | -0.3 | |
| hypercholesterolemia (High Cholesterol) | 0.2 | 0.2 | |
| hyperglycemia | 0.3 | 0.3 | |
| hypertension (High Blood Pressure | 0.8 | -0.8 | |
| Hypothyroidism | 0.3 | -0.3 | |
| Hypoxia | 0.6 | -0.6 | |
| IgA nephropathy (IgAN) | 1.1 | 0.4 | 1.75 |
| Inflammatory Bowel Disease | 1.4 | 1.4 | 0 |
| Insomnia | 0.3 | -0.3 | |
| Intelligence | 0.3 | 0.3 | |
| Intracranial aneurysms | 0.2 | 0.5 | -1.5 |
| Irritable Bowel Syndrome | 1.4 | 1 | 0.4 |
| Juvenile idiopathic arthritis | 0.3 | -0.3 | |
| Liver Cirrhosis | 1.9 | 1.6 | 0.19 |
| Long COVID | 2.1 | 3.5 | -0.67 |
| Low bone mineral density | 0.8 | 0.6 | 0.33 |
| Lung Cancer | 1.4 | -1.4 | |
| ME/CFS with IBS | 0.3 | -0.3 | |
| ME/CFS without IBS | 0.2 | 0.7 | -2.5 |
| Metabolic Syndrome | 2.2 | 2.6 | -0.18 |
| Mood Disorders | 3.3 | 2.7 | 0.22 |
| Multiple Sclerosis | 1 | 1.3 | -0.3 |
| Multiple system atrophy (MSA) | 0.6 | 0.6 | 0 |
| Neuropathy (all types) | 0.7 | 0.6 | 0.17 |
| neuropsychiatric disorders (PANDAS, PANS) | 0.5 | -0.5 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 1 | 0.8 | 0.25 |
| Obesity | 1.7 | 2.4 | -0.41 |
| obsessive-compulsive disorder | 0.2 | 1.3 | -5.5 |
| Osteoarthritis | 0.3 | 0.3 | 0 |
| Osteoporosis | 0.3 | -0.3 | |
| Parkinson's Disease | 0.2 | 2.3 | -10.5 |
| Polycystic ovary syndrome | 0.3 | 0.3 | |
| primary biliary cholangitis | 1.1 | 1.1 | |
| Psoriasis | 0.4 | 0.6 | -0.5 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 1.5 | 2.1 | -0.4 |
| Rosacea | 0.3 | -0.3 | |
| Schizophrenia | 1.4 | 0.3 | 3.67 |
| scoliosis | 0.4 | 0.2 | 1 |
| sensorineural hearing loss | 0.3 | -0.3 | |
| Sjögren syndrome | 0.3 | 0.8 | -1.67 |
| Sleep Apnea | 0.6 | 0.2 | 2 |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.3 | -0.3 | |
| Stress / posttraumatic stress disorder | 1.1 | 0.5 | 1.2 |
| Systemic Lupus Erythematosus | 1.1 | 1.2 | -0.09 |
| Tic Disorder | 0.5 | -0.5 | |
| Type 1 Diabetes | 0.5 | 0.5 | 0 |
| Type 2 Diabetes | 2.2 | 2.4 | -0.09 |
| Ulcerative colitis | 1.4 | 1.3 | 0.08 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.